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In May of 2004, the Tennessee General Assembly passed the Medication Error Reduction 
Act of 2004 (MERA), which amended Title 63 of the Tennessee Code Annotated and as of July 1, 
2004, defined several new criteria with which all written and electronic prescriptions must comply. 
The following research demonstrates that a majority of phannacists are aware of the 11ERA 
legislation, but believe that a considerable number of prescriptions still do not comply with the new 
criteria. Additionally, an independent analysis of prescriptions showed that the majority of received 
orders were in fact noncompliant with l\.1ERA legislation. 
Though they bear a significant fraction of the responsibility for medications-related errors, 
phannacists can do little to ensure that prescriptions comply with the legislation. Phannacists can 
only correct or modify noncompliant prescriptions with approval of the authorized prescriber. As a 
consequence, the Act is only effective if prescribers are enforcably held accountable for written and 
electronic prescriptions. The Tennessee General Assembly has introduced legislation for the Spring 
2005 session to revise l\.1ERA with the input of the Board of Medical Examiners. As evidenced by 
this research, such revisions are necessary and would allow physicians and phannacists to share a 
more equal responsibility for the reduction of medication-related errors, thus promoting better 
health and safety for Tennessee patients. 
Keywords: Medication Error Reduction Act (MERA), legibility law, prescription legibility, 
medication errors, phannacy, phannacist sUlVey 
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Introduction . . . 
Medications-related errors first came to the forefront of the healthcare mdustry Wlth a senes 
of reports published by the Institute of Medicine. The firs~ report of this se~es, To E.rr is HU1'ltln 
(Kohn, Corrigan, Donaldson) addressed the overall quality of healthcare m Amenca and the 
consequences of preventable errors on patient health. Since the publication of this startling report 
in 2000, medications-related errors have increasingly become the subject of lawsuits and news 
headlines. To reduce and prevent these errors, many states have enacted new standards for the 
transmission of patient medical infonnation, such as written and electronic prescriptions. 
As described in the Fall 2004 issue of Terrn!Ssee Phann:teist, the Tennessee General Assembly 
made several additions to the Tennessee Code Annotated (Title 63) by enacting the "Medication 
Error Reduction Act of 2004 (MERA)". The purpose of this act was to create a standard with 
which written and electronic prescription orders must comply, intending to reduce or prevent 
medications-related errors l • The new standards set by MERA address several issues of prescription 
legibility and include the following: 
• Written and electronic orders for a drug must be legibly printed or typed. 
• Written and electronic orders for a drug must be signed on the date issued. 
• The drug quantity must be written in both letters and numerals. 
The aforementioned standards accompany those previously outlined in Title 63, which 
dictate that prescriptions must contain the name of the prescriber, the name and strength of the 
drug prescribed, instructions for proper use of the drug, and the month and day that the prescription 
was issued. Coupled with the new prescription criteria outlined in MERA, these more clearly-
defined standards help reduce the potential for phannacist error. 
The purpose of MERA- to reduce and prevent medications-related errors- can only be 
effective if all medical professionals comply with the law. Because the new legislation amends 
several sections of Title 63, the new criteria applies to all medical professionals involved in the 
prescription process, including physicians, dentists, optometrists, nurses, and phannacists. Without 
proper education and enforcement of the new legislation on all parties involved, the Act can do little 
to reduce or prevent medications-related errors. Promoting the overall safety and health of patients 
in Tennessee requires the cooperation of authorized prescribers and not simplyphannacists. 
The primary function of this research was to evaluate the overall awareness among 
phannacists with the Medication Error Reduction Act and prescriber compliance with the new 
legislation since its initiation in July of 2004. This was accomplished by two procedures, an on-site 
survey of area phannacists, and an observational analysis of prescriptions dated after July 1, 2004. 
The purpose of the survey procedure was to assess the level of phannacist awareness and the 
perceived levels of noncompliance regarding prescriptions received since July 1,2004. The purpose 
of the observational analysis was to quantify the levels of noncompliance beyond phannacist 
perceptions by analyzing individual prescriptions. It is expected that the results from these two 
procedures will demonstrate the overall effectiveness of the Act in terms of phannacist awareness, 
the level of noncompliance among authorized prescribers, and potential avenues for improving 
future legislation. Because the Tennessee General Assembly has introduced legislation for the 
Spring 2005 session to revise the law, this research is especially significant in highlighting the need 
for such revisions. 
Methods 
I State of Tennessee General Assembly. PublicA as, Chapter No. 678. May 2004. 
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As mentioned previously, this research was composed of two independent procedures, one 
that swveyed responses of pharmacists to MERA and its effectiveness, and a second procedure to 
quantify prescriptions that do not comply with both the new criteria and those previously outlined in 
Title 63. 
Procedure 1, Phannacist Survey. The swvey was compiled to address several issues, including 
pharmacist awareness, the level of noncompliance among received prescriptions, and potential 
methods for further reducing medications-related errors. To detennine these items, the swveywas 
composed of the following questions: 
1) .Are you aware that the Tennessee state legislature passed the Medication Error Reduction 
Act in July 2004, a regulation that defines certain criteria with which medication infonnation 
must comply? Resparxlents uere giren the qnim if selecting "Yes"» or "No»; an att:aOxd shret c.mtaimd 
a Sumtnlry if the legjslatWn for any respon:Jents selecting "No». 
2) Of the prescriptions you have received sine July 1, 2004, what percentage of them do you 
feel are fully (100%) compliant with the criteria defined by MERA? Resparxlents uere gf'l£n the 
cption if cJ;wing 0lX! if.foe options, "0-20%». "21-40%», "41-60%», "61-80%» and "81-100%». 
3) Of the prescriptions you have received since July 1, 2004, what percentage of them do you 
feel are at least partially compliant with the criteria defined by MERA? &Jxnlents uere giw'l 
the sam! set if dxia!s famd in Qiestion 2 
4) Of the criteria outlined in MERA, which one do you feel is most often non-compliant? 
Resparxlents uere gf'l£n the cption if cJ;wing 0lX! if the fdlauirrg, ansuers: "A. Prescription is na printed 
(in either 1'UHJtrSne harrlwiting or from a canputer print-aa) », "B. Prescription is na sigrm, by licensed 
prrfessional», "C Nam! ani s~ if mr1icatian is na irKiuded an the prescription», "D. Medication 
quarrliry is na witten in bah rrmrbers and /etters», "E. Prescription instruaions are na irKiuded», "P. 
Prescription is na dated», or "G Pmcription is na sigrm, an the day if order. » 
5) I feel that the MERA legislation is necessary and will significantly reduce medication errors. 
Resparxlents uere gJ'l£n the cptian to cJ;we 0lX! if the f~ "Strurlfiy AgrreJJ, "Agrre", "Neutral", 
"Disagree", am "Strrlnfiy Disagree. " 
6) What else do you think could be done to prevent or reduce medications errors? &Jxnlents 
uere giw'l the qnim to cJ;we all that they felt applied from the fdlauirrg, cptians: "A. Ph)sUians shaJd 
in1ude the reasa(s)/irr1icatiat(s) for prescribing, a certain mr1icatian", "E. Ph)sUians ani/or 
mmufaaurers shaJd mike a SfXrial iffort to darify samd-alike/la}e-alike nam:s», "C Ph)sUians shaJd 
re requim/ to darify abl:nr?datians or ronpletely w7te aft si~. " 
7) Would you favor a system where all prescriptions are transmitted electronically? Resparxlents 
uere gf'l£n the qnim if cJ;wing "Yes"» or "No". 
After constructing the sUIVey, a directory of 101 retail phannacies (independent and chain) 
in the greater Knoxville area was compiled to generate a random sample. Prior to choosing a 
random sample, cotporate representatives for the major chain phannacies were contacted for swvey 
approval. One major chain opted not to participate, reducing the number of potential phannacies 
from 101 to 90. A stratified random sample of 70 pharmacies was then taken from the directory so 
that all participating chains would be represented. 
On several days in December and January of 2004-2005, on-duty pharmacists at each of the 
chosen practice sites were asked to respond to the swveyand were given the option to either 
participate in person or to complete the swveyat their convenience. Out of the 70 phannacists 
approached for the swvey, 68 (97%, N =68) agreed to participate. Aside from answering the 
provided questions, phannacists were also encouraged to add any additional comments regarding the 
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research or the MERA legislation in general. The surveys were then collected and all of the data 
compiled. 
Procedure 2, Prescription Observations. The prescription analysis was performed at a 
community phannacy centrally located in East Tennessee, where the majority of prescription orders 
are received from both the greater Knoxville and Chattanooga areas. To quantify the levels of 
noncompliance among received prescriptions, 500 printed or handwritten prescriptions dated after 
July 1, 2004 were pulled randomly in lots of 100. Each prescription was then examined for the 
criteria listed in Tide 63, including whether the prescription was printed (in non-cursive handwriting 
or type-written), contained all of the necessary information (name of prescriber, name and strength, 
quantity, instructions for proper use, date, and signature on the date issued), and had the drug 
quantity written in both letters and numerals. Additionally, of those quantities not written in letters 
and numerals, the number of controlled substances was also noted. Each item of noncompliance 
was then recorded and compiled. 
Results 
Phannacist Survey 
Table 1 contains survey responses to question 1, which assessed the overall awareness of the 
Medication Error Reduction Act among 
pharmacists. As illustrated in the table, 71% of 
the pharmacists surveyed responded that they 
were aware of the MERA legislation, while 29% 
were not. Because the remainder of the survey 
depended on information found in the Act, 
respondents who were unfamiliar with its 
contents were supplied with a short summary 
describing the new legislation. 
Table 1. Awareness 
Are you aware that the Tennessee state legislature passed 
the Medication Error Reduction Act in July 2004, a 
regulation that defines certain criteria with which 




Table 2 contains data from survey questions 2 and 3, which sought to identify the percentage 
of prescriptions that pharmacists felt were fully or partially compliant with the new criteria found in 
Table 2. Perceived Levels of Compliance 
Level of Compliance Percentage 
Compliant 
Full Compliance. Of the 0-20% 
prescriptions you have received 21-40% 
since July 1, 2004, what percentage 41-60% 
of them do you feel are fully 61-80% (100%) compliant with the criteria 
defined by MERA? 81-100% 
Partial Compliance. Of the 0-20% 
prescriptions you have received 21-40% 
since July 1, 2004, what percentage 41-60% 
of them do you feel are at least 61-80% partially compliant with the criteria 












the MERA legislation. The table shows 
that 17.6% of pharmacists felt that 
between 0-20% of received prescriptions 
were fully compliant with the MERA 
legislation. Likewise, 25.0% felt that 21-
40% of received prescriptions were fully 
compliant with the new legislation. 
Further details can be seen in the table. 
The bottom portion of Table 2 
describes the percentage of prescriptions 
that pharmacists felt were at least partially 
compliant with the new criteria. As 
shown in the table, 22.1% of the 
pharmacists surveyed felt that 41-60% of 
the prescriptions they had received since 
. July 1, 2004 were at least partially 
comp~t and 27.9% felt that 61-8?%. of prescriptions were partially compliant. 44.1% of the 
pharmacISts surveyed felt that the maJonty (81-100%) of received prescriptions were at least partially 
compliant with the new legislation. 
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Table 3 Table 4 
Of the criteria outlined in MERA, which one do you feel is most often Pharmacist Response to the necessity 
and significance of MERA legislation. non-compliant? 
Response Score Response Score 
Rx is not printed (non-cursive handwriting or typewritten) 41.2 % Strongly Agree 51.5 % 
Rx is not signed by a licensed professional 4.4 % 33.8% Agree 
Name and strength of medication is not included on Rx 5.9% Neutral 13.2% 
Quantity is not written in letters and numerals 45.6% Disagree 1.5 % 
Rx instructions are not included 0% Strongly Disagree 0% 
Rx is not dated 2.9% 
Rx is not signed on the day of order 0% 
The criteria which phannacists felt were the most often noncompliant can be found in Table 
3. The data here contains the new items outlined in MERA as well as those previously found in 
Title 63. The table illustrates that most phannacists felt that the two criteria most often 
noncompliant are that the prescription is either not printed (41.2%) or that the medication quantity 
is not written in both letters and numerals. Other significant criteria included that the prescription 
was not signed by a licensed professional (4.4%), not dated (2.9%), or that it does not include both 
the name and strength of the medication (5.9%). 
Table 4 describes the overall reaction of phannacists to the Medication Error Reduction Act. 
More specifically, it illustrates whether phannacists feel the MERA legislation is necessary and will 
significantly reduce medications-related errors. Over half of the respondents (51.5%) strongly 
agreed that the Act was necessary and will significantly reduce errors. Another 33.8% of 
phannacists agreed that the law is necessary, while only 13.2% were neutral and 1.5% disagreed, 
believing that the Act would not significantly reduce medications errors. 
In Question 6, three choices were presented as potential means for the further reduction or 
prevention of medication errors. 
Table 5 illustrates these results. 
Because respondents could choose 
all that apply, the sum of the 
percentages do not equal 100%. 
.As the table indicates, 80.8% of 
the phannacists surveyed felt that 
including the reasons or 
indications for medications would 
aid in preventing or reducing 
medications-related errors. 
Another significant percentage 
(60.3%) felt that physicians should 
be required to clarify abbreviations 
Table 5 
What else do you think could be done to prevent or reduce medications 
errors? 
Response Score* 
Physicians should include the reason(s)/indication(s) for 80.8% 
prescribing a certain medication. 
Physicians and! or manufacturers should make a special 47.1 % 
effort to clarifysound-a1ike/look-a1ike names. 
Physicians should be required to clarify abbreviations or 60.3 % 
completely write out sigs. 
* Respanlents cmld ~e all that applie1; the sum if these perrentags das m 
81ua{100% 
or completely write out sigs. Finally, a smaller percentage (47.1%) of respondents felt that clarifying 
sound-alike or look-alike names would significantly prevent or reduce medications errors. 
Table 6 
Would you favor a system where all 





Finally, the last question of the survey assessed 
whether phannacists would favor a system in which all 
prescriptions were transmitted electronically. The results of 
this data are included in Table 6. Over three-quarters 
(75%) of the respondents stated that they would favor a 
system where all prescriptions were transmitted 
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electronically, whereas the remaining 25% would not favor such a system. 
Prescription Observations 
To quantify the relative level of noncompliance with MERA, 500 prescriptions dated after 
July 1,2004 were pulled from file and analyzed for the criteria outlined in the new legislation as well 
as that previously found in Title 63. To qualify for this analysis, the prescriptions had to be 
handwritten or printed (either from the physician's office or via fax); call-in prescriptions were not 
considered. The prescriptions were drawn in lots of 100 from a random five business days. Each 
prescription was then analyzed individually and noncompliant criteria were recorded. Table 7 lists 
the results from these observations. 
Because a number of the prescriptions analyzed were noncompliant with multiple criteria, 
the sum of the percentages here does not equal 100%. As shown in the table, 56.8% of the 
prescriptions observed were not printed (in non-cursive handwriting or from a computer print-out). 
10.4% of the prescriptions did not contain the name of the prescriber. Note that prescriptions were 
scored for this criterion if either: 
1) The prescription was not signed, or 
2) The prescription was a hospital or 
institution blank and included no 
additional means of identification 
other than a signature. 
6.2% of the prescriptions did 
not have the name and strength of the 
drug included. By far, the most 
noncompliant criterion was that the 
medication quantity was not written in 
both letters and numerals, with 70.8% 
of the observed prescriptions being 
noncompliant. More importantly, 
15.2% of the total prescriptions were 
written for controlled substances and 
did not have the quantity written in 
Table 7 
Prescription Observations 
Criteria Score (n=500) 
Rx was not printed 56.8% 
Name of prescriber not included* 10.4% 
Name and strength of drug not included 6.2% 
Quantity not written in letters and 70.8% 
numerals 
(0Jntrdlad substam5) 15.2% 
Proper instructions not included 2% 
Rx was not dated 2.6% 
Rx was not signed on the date issued 3% 
* "Nanr if presC7'ikr rKX in:iu:le:l" r{enrrl /;ah txJ tlne prescriptions 7.iherr! 
the presC7'ikr did n:t: sign the presoiptian or in the case 7.iherr! the prescription 
W1S a hapital or institution liank ani only a sif!.nature W1S iniz&d 
both letters and numerals. The final three criteria listed in the table were that proper instructions 
were not included, the prescription was not dated, and that the prescription was not signed on the 
date issued, with scores of 2%, 2.6%, and 3%, respectively. 
Figures 1-4 illustrate actual prescriptions analyzed in this study. To comply with I-llPAA 
regulations and to protect identities of the prescribers, all identifiable information has been blurred 
out or removed altogether. 
Discussion 
The pwpose of the survey was to evaluate the overall awareness of the Medication Error 
~~uction Act am<:>~ pharmacists ~d its perceived effectiveness. The results of the survey clearly 
mdicate that a maJonty of pharmacISts (almost three-fourths) were familiar with the Act and its 
contents. r:o:vever, becaus~ they require. verificatio? ~d approval f;om the authorized prescriber 
?efore ~odifying or ~orrectmg ~oncompliant p~scnpt1ons, pharmacISts have relatively little power 
m assunng the compliance of wntten or electroruc prescriptions. 
. When a question regarding the accuracy or validity of a prescription arises, the pharmacist is 
reqUIred by law to contact the authorized prescriber for verification prior to dispensing the 
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medication. The pharmacist may then be faced with trying to contact the prescriber through a 
receptionist or nurse, which as several respondents noted, often results in an extended game of 
"phone tag." Though the law allows the pharmacist to delay dispensing the prescription until 
verification is made, it does nothing to alleviate the dilemma of having to tell a waiting customer that 
verification from the prescriber is needed and may take anywhere from a few minutes to several 
hours to receive. 
Despite the new standards set by MERA, phannacists believed that the new legislation 
would do little to reduce medications-related errors if it was not being effectively enforced. This was 
further evidenced by their responses to questions 2 and 3, which sought to evaluate how many 
prescriptions they perceived were being fully or partially compliant with the new criteria. As was 
seen in the results, 25% of the respondents believed that only 21-40% of the prescriptions they had 
received were fully compliant with the new criteria. Also significant was the fact that 22.1% believed 
that 41-60% of received prescriptions were compliant. Although 23.5% believed that 61-80% were 
fully compliant with MERA, many conunented that this number is still far below the number of 
prescriptions that shadd be fully compliant. 
Several pharmacists also noted that the types of prescriptions they received often influenced 
the perceived levels of compliance. .At some practice sites, the majority of prescriptions carne from 
electronic orders, where the levels of noncompliance are generally low. Other pharmacies, however, 
which receive the majority of their prescriptions as handwritten orders, reported a higher number of 
noncompliant prescriptions. 
The criteria that survey respondents felt were most often noncompliant was that the 
prescriptions were either not printed (in non-cursive handwriting or from a computer print-out) or 
that they did not have the quantity written in letters and numerals. As will be described later, these 
perceptions were consistent with independent observations of actual prescriptions. Many of the 
respondents conunented that it was difficult to simply choose one of the options listed on the 
survey. Again, this was also consistent with prescription analysis, as many contained multiple 
violations. 
Despite not being effectively enforced, the majority of pharmacists believed that this t}pe of 
legislation is necessary and, if enforced, would reduce medications-related errors. To make the 
legislation more effective, however, respondents indicated that including the indications for 
prescribing certain medications and completely writing out abbreviations would further prevent or 
reduce medications errors. A smaller percentage felt that physicians and manufacturers should make 
a special effort to clarify sound-alike and look-alike names, but that this t}pe of modification would 
be unnecessary if prescriptions were already compliant with the other criteria. In addition, several 
respondents also noted that many manufacturers already make a special effort to clarify sound-alike 
and look-alike names, such as distinguishing between hydr-OXY-zine and hydr-ALA-zine. 
The final question in the survey assessed whether pharmacists would favor an all-electronic 
transmission system as a potential means for reducing or preventing medications- related errors. 
Three-fourths of the pharmacists surveyed indicated that they would favor a system where all 
prescriptions were transmitted electronically. Several pharmacists responded that this would not 
only reduce and prevent medications-related errors- it would also help to reduce the number of 
potential forgeries. An electronic system reduces errors by transmitting prescriptions that are 
completely legible and, as will be discussed later, it also eliminates the need for receptionists to call in 
prescriptions. 
Though a majority of pharmacists favored an all-electronic prescription system, some had 
reservations. One issue raised was that, although there are a reduced number of errors, some have 
been known to occur in physicians offices which utilize electronic devices (such as PDAs) to 
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transmit prescnptlons. Physicians may unknowingly choose the wrong strength or quantity simply 
by a misplaced pen stroke. 
Several respondents also had concerns with all prescriptions being transmitted electronically, 
citing that certain medications, such as controlled substances, should still be transmitted by 
traditional means. Additionally, a few noted that an all-electronic system would be a prime target for 
abuse or manipulation by highly-skilled personnel. Such a system would require high levels of 
encryption as well as safeguards to prevent abuse. A final concern expressed by several of the 
respondents was the cost of implementing an electronic transmission system, an issue expected to be 
considerably more significant for independent and smaller community pharmacies. 
WI' 
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Fig 1. Prescription legibility 
Is the smnl mr1ication here Olexa 20ng or O/ebrex 200rrg? 
FOR , •.. ---------.:!.!L--~ . " ................ . 
Jl!< I ~ II ~. ;;" . ... . . ry" . 'J '1 0,,-
ADDREJ;S:. ...•... ~.-"" _ • .z ~.~.. DATJ ... _. ''' ... 
B ~\Ui ~ I g- rff.., -, A~ Pf1 
f'- lc., ~ 
INIH,I" 
Rctill_-=r... _ Times 
MD M.O. 
Fig 2. Legibility of controlled substances 
This mr1ication 'WIS first rristaken for L artab, but 'WIS later a:JrYIrt8:i 
to Lam:til, after the last 'lIlJ1'd 'WIS deterrrimJ as ~ "dianhea»; 
Phyician 'WIS aJI1J:aCt8i for wifoati.on. 
Following the survey, respondents were 
given the opportunity to ask questions or give 
any additional comments regarding this research 
or the Medication Error Reduction Act itself. 
One pharmacist noted another potential source 
of error which may result from 
miscommunication between the physician and 
pharmacy through non-licensed personnel, such 
as receptionists and medical assistants. She 
noted that pharmacists, authorized prescribers, 
and pharmacy technicians are licensed or 
registered by the State of Tennessee. However, 
non-licensed personnel may be just as involved 
in the transfer of medical information between 
the physician and the pharmacy, but are not 
currently required to have any type of formal 
education. Other pharmacists confirmed this 
observation, noting specific instances where 
receptionists were unable to pronounce certain 
medications or were asked to spell out generic 
prescription orders to the pharmacist over the 
telephone. 
The observational analysis of 
prescriptions pennitted an actual quantification 
of noncompliant criteria, confinning the 
perceptions found in the pharmacist survey. As 
was seen in the survey responses, the two most 
noncompliant criteria were that the 
prescriptions were not printed (in non-cursive 
handwriting or from a print-out) or that they 
did not have the medication quantity written in 
letters and numerals. Moreover, 15.2% of the 
medications noncompliant with this criterion 
were controlled substances, where the 
likelihood of forgery is typically higher. It can be reasonably inferred that requiring medication 
quantities to be written in letters and numerals is an effort to reduce the prevalence of forgery and 
abuse of controlled substances. However, when prescribers fail to put this component of the 
MERA legislation into practice, the effort to reduce forgery is thus cancelled out. 
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Prescriptions that either did not have t <~nm = 
the signature of the prescribing physician or "ffi =w ¥hi 
were simply a clinical blank and contained only 
:w 
the signature of the prescriber (and not a 
printed version of the name indicated elsewhere 
on the prescription) were scored as not 
including the "name" of the prescribing 
physician. Larger institutions, such as medical 
centers and hospitals have a number of 
physicians on-duty at any particular time, many 
of which use the same blanks. As a result, 
verifications on prescriptions may be difficult to 
obtain. Many prescriber signatures are 
unintelligible at best and make it virtually 
impossible to contact the physician if 
verification of a prescription is required. Simply 
requiring that a prescriber print his or her name 
along with the signature would easily eliminate 
this problem 





Dispense: 93 (ninety-tIlTCC:) 
label: 
Tate I (one) cap PO 3 (thrcc:) tim« daily, 




Mlly !lu?s!.\lWII ." Uispense as written 
Fig 3. Use of computer-generated prescriptions 
The abar.e imt~ dem:mstrates the ad:u:mta~ if a amputeriz£d S)5tem 
7Jhere ME RA criteria are folji1k1 autarntimJJy. 
also illustrated that over 50% of the prescriptions were not written in non-cursive handwriting or 
were not from a computer print-out. Writing a prescription in cursive automatically introduces the 
potential for error, as pharmacists must interpret even the most subtle pen stroke. Physician 
handwriting has always been the subject of tongue-in-cheek humor, even being highlighted in "Can 
~rt=' 
" . Zft" _ ..,"{J'W11np'- -
NAME t1 " rr "AGE 
ADDRESS ___ DKn: I\~\Q::> 
\<eC1~ SoD4 
.t.~ (~~e,\q'"'t) 
~ ~ll.k> ~o ~i.a. "14d0.4S 
a LABEL 
~34PRN 
You Read These Rxs?", a feature in every issue of 
the NO:> A's Pharmuy Tim:s. As examples of the 
problems associated with legibility issues, actual 
prescriptions from this analysis can be viewed in 
Figures 1 and 2, showing the need for this type of 
legislation. Figure 3 illustrates the advantage of 
using a computer-generated print-out for 
prescriptions. Handwritten prescriptions, as seen in 
Figure 4, can also comply with all of the regulations 
outlined in the new legislation. Humor aside, 
prescriber handwriting can be a serious issue as a 
simple misinterpretation of a prescription may lead 
;UBSTJTUTI"A-LL-OWE-,D"~m DlPl£NSI!ASWRflTI£N ,M"ll" to a potentially disastrous medication error. In 
Fig 4. Handwritten compliant prescription other words, the life of the patient may be at 
The abar.e fig;qe dem:mstrates a harr1witten jJrfScription stake- writing legibly seems hardly the sacrifice to 
a:npliant Wth the mocriteria. simply ensure the health and safety of the patient. 
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Conclusion 
Overall, the phannacists sUIVeyed in this research believed that the MERA legislation is 
necessary, but in order to be completely effective, it should be enforced on authorized prescribers as 
well. After all, pharmacists are only a piece of the "error puzzle" - the responsibility of reducing 
and preventing medications-related errors should be shared by the prescribers who write 
prescription orders and the phannacists who dispense them. As a result, the Medication Error 
Reduction Act could readily accomplish its goal of reducing or preventing medications errors if 
properly enforced by the appropriate government entities. 
As this research has shown, a majority of phannacists are well aware of the new legislation; 
additionally, nearly all of the pharmacists sUIVeyed agreed that such legislation is necessary. 
However, the law grants pharmacists little power in modifying or correcting noncompliant 
prescriptions, because approval by the authorized prescriber is required. As described above, 
contacting the authorized prescriber almost always involves a considerable delay in dispensing a 
prescription. In many cases, the one or two hours a customer is required to wait is one or two hours 
too many. Most importandy, this delay may be completely unnecessary- if its provisions are 
followed correcdy, the Medication Error Reduction Act gready reduces the possibility of delaying a 
prescription, especially if the verification is to simply clarify an ambiguous or illegible word. 
Therefore, this research demonstrates the need for revising the Medication Error Reduction 
Act, as proposed by the General Assembly for the Spring 2005 session. Because pharmacists cannot 
prescribe medications and their ability to modify prescriptions is subject to the approval of the 
authorized prescriber, their responsibilities to ensure compliance with the MERA legislation can 
only go so far- prescribers and phannacists together must share the responsibility of reducing and 
preventing medications-related error. It is evident that legislation such as MERA is a step in the 
right direction to promote better health for Tennessee residents; however, as seen in this research, 
the law is only effective if Tennessee prescribers are also enforced to comply. So far, the Board of 
Pharmacy has taken the steps necessary to enforce the law on Tennessee pharmacists, but is 
powerless if prescribers are not held to this same standard. It is time for Tennessee prescribers-
physicians, dentists, optometrists, and other professionals alike- to be held to that same standard. 
